Connection
Richard Lindrooth to Drug Costs
This is a "connection" page, showing publications Richard Lindrooth has written about Drug Costs.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.332 |
|
|
|
-
Owsley KM, Hasnain-Wynia R, Rooks RN, Tung GJ, Mays GP, Lindrooth RC. US Hospital Service Availability and New 340B Program Participation. JAMA Health Forum. 2024 May 03; 5(5):e240833.
Score: 0.209
-
Sasso AT, Lurie IZ, Lee JU, Lindrooth RC. The effects of expanded mental health benefits on treatment costs. J Ment Health Policy Econ. 2006 Mar; 9(1):25-33.
Score: 0.059
-
Bradley CJ, Liang R, Lindrooth RC, Sabik LM, Perraillon MC. High-Cost Cancer Drug Use in Medicare Advantage and Traditional Medicare. JAMA Health Forum. 2025 Jan 03; 6(1):e244868.
Score: 0.055
-
Lacey L, Mauskopf J, Lindrooth R, Pham S, Saag M, Sawyer W. A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US. Pharmacoeconomics. 1999; 15 Suppl 1:23-37.
Score: 0.009